Dr. Saba Bekele, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,985 | 87 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $700.87 | 27 | $0 (2024) |
| PFIZER INC. | $408.23 | 23 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $301.61 | 15 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $159.79 | 3 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $114.60 | 6 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $60.50 | 2 | $0 (2024) |
| ABBVIE INC. | $55.32 | 2 | $0 (2024) |
| ZS Pharma. Inc. | $47.43 | 2 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $42.11 | 2 | $0 (2017) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $41.70 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $214.81 | 8 | Mallinckrodt Hospital Products Inc. ($60.50) |
| 2023 | $137.13 | 6 | Janssen Pharmaceuticals, Inc ($51.82) |
| 2022 | $312.55 | 14 | Janssen Pharmaceuticals, Inc ($131.30) |
| 2021 | $98.91 | 4 | Janssen Pharmaceuticals, Inc ($60.89) |
| 2020 | $76.53 | 4 | Janssen Pharmaceuticals, Inc ($27.80) |
| 2019 | $337.32 | 15 | Janssen Pharmaceuticals, Inc ($174.91) |
| 2018 | $295.83 | 15 | PFIZER INC. ($128.06) |
| 2017 | $511.66 | 21 | AstraZeneca Pharmaceuticals LP ($144.79) |
All Payment Transactions
87 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: CRITICAL CARE | ||||||
| 09/12/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.87 | General |
| Category: Cardiovascular | ||||||
| 07/11/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $34.90 | General |
| Category: CRITICAL CARE | ||||||
| 06/06/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/09/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.85 | General |
| Category: Cardiovascular | ||||||
| 04/17/2024 | ABBVIE INC. | DALVANCE (Drug), AVYCAZ, TEFLARO | Food and Beverage | In-kind items and services | $31.49 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/14/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $30.27 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/01/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/06/2023 | AbbVie Inc. | DALVANCE (Drug), TEFLARO, AVYCAZ | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/26/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/08/2023 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $17.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/25/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/31/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/02/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/22/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/28/2022 | PFIZER INC. | ELIQUIS (Drug), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/13/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/15/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/23/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/09/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $31.33 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/09/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $1.80 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/26/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/14/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.97 | General |
| Category: Cardiovascular | ||||||
| 03/31/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $36.63 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/24/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $36.09 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 462 | 725 | $250,143 | $66,614 |
| 2022 | 4 | 479 | 849 | $261,821 | $71,159 |
| 2021 | 5 | 511 | 1,071 | $299,062 | $85,897 |
| 2020 | 4 | 252 | 481 | $144,387 | $39,006 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 142 | 267 | $108,402 | $28,985 | 26.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 177 | 311 | $83,970 | $22,172 | 26.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 143 | 147 | $57,771 | $15,457 | 26.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 219 | 537 | $131,565 | $35,681 | 27.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 88 | 134 | $47,034 | $12,748 | 27.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 113 | 118 | $42,362 | $11,588 | 27.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 59 | 60 | $40,860 | $11,142 | 27.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 243 | 765 | $181,305 | $52,123 | 28.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 143 | 144 | $50,256 | $14,496 | 28.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 59 | 59 | $39,176 | $11,129 | 28.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 50 | 72 | $24,264 | $7,020 | 28.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 16 | 31 | $4,061 | $1,129 | 27.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 123 | 329 | $83,895 | $22,619 | 27.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 77 | 78 | $29,484 | $7,988 | 27.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 41 | 63 | $23,121 | $6,263 | 27.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 11 | 11 | $7,887 | $2,136 | 27.1% |
About Dr. Saba Bekele, MD
Dr. Saba Bekele, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2013. The National Provider Identifier (NPI) number assigned to this provider is 1437598851.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Saba Bekele, MD has received a total of $1,985 in payments from pharmaceutical and medical device companies, with $214.81 received in 2024. These payments were reported across 87 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,985).
As a Medicare-enrolled provider, Bekele has provided services to 1,704 Medicare beneficiaries, totaling 3,126 services with total Medicare billing of $262,676. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Internal Medicine
- Location Bronx, NY
- Active Since 06/19/2013
- Last Updated 09/19/2016
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1437598851
Products in Payments
- XARELTO (Drug) $700.87
- ELIQUIS (Drug) $502.93
- ENTRESTO (Drug) $301.61
- BRILINTA (Drug) $207.22
- TERLIVAZ (Drug) $60.50
- DALVANCE (Drug) $55.32
- LANTUS (Drug) $42.11
- LifeVest (Device) $41.70
- JANUVIA (Drug) $19.91
- CHANTIX (Drug) $19.90
- CLEVIPREX (Drug) $17.86
- CLEVIPREX 25MG/50ML (Drug) $14.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Bronx
Dr. David Altschul, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $394,687
Edvard Skripochnik, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $127,559
Dr. Cynthia Armand
Student in an Organized Health Care Education/Training Program — Payments: $68,024
Dr. Eric Woods, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $40,336
Ms. Kavita Gupta, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $31,772
Dr. Dmitriy Nevelev, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $30,107